CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 15.008
EU - Europa 4.429
AS - Asia 2.582
OC - Oceania 16
AF - Africa 10
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.063
Nazione #
US - Stati Uniti d'America 14.995
CN - Cina 1.737
UA - Ucraina 1.451
IT - Italia 955
TR - Turchia 759
DE - Germania 661
GB - Regno Unito 499
FI - Finlandia 314
SE - Svezia 233
PL - Polonia 153
FR - Francia 89
VN - Vietnam 19
IN - India 17
AU - Australia 14
BE - Belgio 13
CA - Canada 12
JP - Giappone 12
NL - Olanda 11
IE - Irlanda 10
RU - Federazione Russa 10
CH - Svizzera 8
EU - Europa 7
RO - Romania 7
ID - Indonesia 6
IR - Iran 6
BR - Brasile 5
EG - Egitto 5
HK - Hong Kong 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
ES - Italia 3
IL - Israele 3
NO - Norvegia 3
SG - Singapore 3
AT - Austria 2
CO - Colombia 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 22.063
Città #
Fairfield 2.049
Woodbridge 1.907
Jacksonville 1.591
Houston 1.208
Chandler 1.143
Ashburn 880
Ann Arbor 861
Wilmington 761
Seattle 713
Cambridge 590
Izmir 530
Nanjing 526
Princeton 331
Beijing 229
Washington 213
San Diego 175
Ferrara 152
Warsaw 152
Shenyang 143
Boardman 135
Nanchang 131
Milan 130
Hebei 101
Addison 87
Changsha 87
Jiaxing 87
New York 70
Dearborn 69
Tianjin 67
Shanghai 58
Jinan 56
Norwalk 46
Kunming 45
Redwood City 38
Zhengzhou 37
Falls Church 36
Mountain View 36
Ningbo 36
Verona 34
London 30
Taizhou 27
Bremen 25
Guangzhou 25
Orange 24
Rome 22
San Mateo 22
Los Angeles 20
Dong Ket 19
Helsinki 19
Augusta 17
Auburn Hills 16
Lanzhou 16
Catania 14
Changchun 14
Chicago 14
Brussels 13
Napoli 13
Pordenone 12
Philadelphia 11
Hangzhou 10
Tappahannock 10
Indiana 9
Messina 9
Bologna 8
Des Moines 8
Hefei 8
Parma 8
Torino 8
Padova 7
Düsseldorf 6
Leawood 6
Mumbai 6
Munich 6
Paris 6
Redmond 6
Turin 5
Aversa 4
Cagliari 4
Kilburn 4
Kyoto 4
Lecco 4
Modena 4
Naples 4
Olomouc 4
Oristano 4
Taipei 4
Taiyuan 4
Vicenza 4
Walnut 4
Aci Catena 3
Anzano Del Parco 3
Bari 3
Bolzano 3
Burlington 3
Chiswick 3
Dallas 3
Dublin 3
Edinburgh 3
Fuzhou 3
Grosseto 3
Totale 16.124
Nome #
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 257
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 205
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 163
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 160
Sindrome epatopolmonare. 154
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 148
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 147
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 135
Models of infection and exacerbations in COPD. 128
Definition, clinical features, investigations and differential diagnosis in asthma. 127
Malattie polmonari primitive da cause dismetaboliche. 127
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 126
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 124
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects 122
null 121
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 120
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 118
null 118
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 117
Convergent sets of data from In Vivo and In Vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 116
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 115
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 115
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 114
null 114
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 113
Airway obstruction in chronic obstructive pulmonary disease. 113
null 111
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 110
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 110
COPD exacerbations: definitions and classifications 106
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 105
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 105
Clinical definition of COPD exacerbations and classification of their severity 104
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 104
Allergen responses modified by a GATA3 DNAzyme 104
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 103
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 103
The level of control of mild asthma in general practice: An observational community-based study 103
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 103
The future of relievers and controllers in asthma therapy. 103
Therapies acting on transcription: overview. 103
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 102
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 102
null 102
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 101
A link between lung injury and inflammatory myopathies: making the diagnosis 101
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 100
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview 100
Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis 100
Chronic Obstructive pulmonary disease and lung cancer: New molecular insights 100
null 100
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 100
Mechanisms involved in lung cancer development in COPD 99
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 99
Extrapulmonary tuberculosis. 99
null 98
Chronic obstructive pulmonary disease international guidelines. 98
Strategies for improving the efficacy and therapeutic ratio of glucocorticoids 97
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 96
Steroid-sparing Strategies: Other Combinations 96
Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease 96
Molecular mechanisms of respiratory virus-induced inflammation. 96
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 96
Degree of control of physician-diagnosed asthma and COPD in Italy. 95
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 95
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 95
null 95
Novel anti-inflammatory treatments for asthma and COPD 95
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 94
Bronchial glomus tumor mimicking a COPD exacerbation 94
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 93
New insights into the molecular mechanisms of corticosteroids actions 93
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 93
null 92
STAT2 activation in smokers and patients with chronic obstructive pulmonary disease 92
Telomere shortening in alveolar macrophages of smokers and COPD patients 92
High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD 92
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 92
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 92
Definition, clinical features, investigations and differential diagnosis in asthma 91
Mechanisms of respiratory virus-induced asthma exacerbations 91
null 91
null 91
Gene-environment interactions in the development of chronic obstructive pulmonary disease 90
New targets for drug development in asthma 90
Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. 90
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 90
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 90
Increased deposition of activated complement in peripheral lung vessels of smokers 90
null 90
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 90
Corticosteroidi, disodiocromoglicato e nedocromile nella terapia dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 89
Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma 89
Pharmacology of airway inflammation in asthma and COPD 89
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease 89
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 89
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 89
null 89
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 88
Cross-talk between pro-inflammatory transcription factors and glucocorticoids 88
Totale 10.649
Categoria #
all - tutte 82.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.740
Totale 95.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.931 0 0 0 0 0 0 0 0 0 0 604 1.327
2019/20205.079 1.009 149 153 740 295 600 405 564 353 529 177 105
2020/20213.532 309 328 155 480 165 397 109 419 60 424 438 248
2021/20222.572 61 287 199 218 74 94 99 163 93 235 267 782
2022/20232.622 351 61 78 324 375 457 69 245 361 25 183 93
2023/2024803 148 173 53 30 87 139 27 47 23 37 39 0
Totale 22.367